Delivery Order SPE2DB20D3103-SPE2DB26FL5A0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a contract ceiling value of $1,503.56. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 26, 2025, for Zymfentra 120 mg/ml pen kits valued at $3,007.12. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of October 20, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for...
- The Defense Logistics Agency awarded a $3,007.12 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zymfentra 120 mg/ml pen (2-pack units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 21, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- On September 22, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,014.24 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pens in a two-pack configuration. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a non-competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,007.12 for Zymfentra 120 mg/ml pens (2-pack quantity) on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,007.12 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with an ultimate completion date of October 7, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award under the company's existing indefinite delivery contract vehicle with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,503.56 on July 24, 2025, for Zymfentra 120 mg/ml pens (2-packs), with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed pricing and represents performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Zymfentra 120 mg/ml pen (2-pack units) with a ceiling value of $3,007.12 under a firm fixed-price contract. This delivery order represents a competitive, non-set-aside award with an ultimate completion date of October 20, 2025. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $3,007.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 2, 2025. This non-competitive delivery order was issued on August 11, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $2,911.28 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on November 5, 2025, with completion expected by November 28, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL5A0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a ceiling value of $3,007.12 and a firm fixed price structure. This contract utilizes a non-competitive set-aside designation and is scheduled for completion by November 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery contract, this award leverages AmerisourceBergen's established relationship with the Defense Logistics Agency to fulfill pharmaceutical supply requirements for federal medical programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a substantial Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The current delivery order for Zymfentra represents a typical transaction within this framework, supporting the Defense Logistics Agency's ongoing medical supply chain operations for the Department of Defense and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/4/25 |